RXMD is working to get a new IR company, as well as working to find the right directors for their move to OTCQB. Both of those will have a huge upward effect on the stock, once they're in play.
In the meantime, I'll take year-over-year revenue increases any day of the week. The business is solid, and that's what matters in the long-term. Everything we're seeing these days over these low volumes are just reindeer games...